Penetration of albendazole sulphoxide into hydatid cysts.
Open Access
- 1 January 1987
- Vol. 28 (1), 75-80
- https://doi.org/10.1136/gut.28.1.75
Abstract
The penetration of albendazole sulphoxide, the principal metabolite of albendazole into hydatid cysts (E granulosus) was measured by means of in vitro animal and clinical studies. The drug freely diffuses across the parasitic membranes. Cyst/serum concentrations of 22% were achieved in patients, longer pre-operative therapy produced higher concentrations.This publication has 17 references indexed in Scilit:
- Pharmacokinetics of albendazole in manEuropean Journal of Clinical Pharmacology, 1986
- ALBENDAZOLE AS A POTENTIAL TREATMENT FOR HUMAN HYDATIDOSISThe Lancet, 1983
- Albendazole in hydatid disease.BMJ, 1983
- Bioavailability and tolerability of mebendazole in patients with inoperable hydatid diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- Chemotherapy for larval echinococcosis in animals and humans: Report of a workshopZeitschrift Fur Parasitenkunde-Parasitology Research, 1982
- Echinococcus granulosus: Permeability of hydatid cysts to mebendazole in miceInternational Journal for Parasitology, 1981
- LONG‐TERM HIGH‐DOSE MEBENDAZOLE FOR CYSTIC HYDATID DISEASE OF LIVER: FAILURE IN TWO CASESAnz Journal of Surgery, 1981
- Analysis of Benzimidazoles in Body Fluids by High-Performance Liquid ChromatographyJournal of Pharmaceutical Sciences, 1980
- Chemotherapy of human hydatid disease with mebendazole. Follow-up of 16 cases.1980
- The permeability of the membranes of experimental secondary cysts of Echinococcus granulosus to [14C]mebendazoleInternational Journal for Parasitology, 1977